FDA Investigator Juanj Wu
Juanj Wu has inspections in 3 countries as of 07 Aug 2023. Juanj Wu has collaborated with a combined 1331 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
46
Last Inspection Date:
07 Aug 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
Switzerland,
United Kingdom of Great Britain and Northern Ireland
Co-Investigator(s):
Allen F Hall,
Amy M Cramer,
Anderson,
Angela Shepas,
Benjamin W Anderson,
Bruce R Burrell,
Carr Sharpe,
Christine I Shaw,
Clinton R Vanblaricom,
Cynthia L Gorveatt,
Daniel J Lahar,
David G Whitman,
David J Gasparovich,
Dejon N Harris,
Dirk L Lincoln,
Doan T Nguyen, PharmD,
Donna Ltartaglino Besone,
Dustin P Tran,
Edwards,
Elizabeth A Dakan,
Eric W Anderson,
Gene D Arcy,
Geoffrey M Leist,
Greg K Keshishyan,
Hanna L Potter,
James A Lane,
James R Fleckenstein,
James R Montero,
Janet Pulver,
Jeffrey S Buckser,
Jeffrey W Shrifter, DPM,
Jenny L Mccardell,
Joey V Quitania,
Juanj N Wu,
Julian C Hanson,
Kelvin Cheung,
Kwong P Lee,
Lee,
Leonard H Lavi,
Leongc,
Leya A Grosch,
Lisa A Bowden,
Mark E Moen,
Marlo Ianm Alintanahin,
Mary R Hole,
Matthew D Schnittker,
Melanie W Pishnery,
Natalie J Ayoub,
Natalie J Reese,
Ngoc B Kelsch,
Paul F Rader,
Rachelle M Deskins,
Rebecca L Stephany,
Richard K Vogel,
Roberta K Smith,
Sara M Onyango,
Sara M Richardson,
Sarah A Hassas,
Scott K Zika,
Seema S Singh,
Selene T Torres,
Shaquenta Y Perkins,
Sharon I Gundersen,
Sonya L Karsik,
Stanley B Eugene, BS, BME,
State Agency,
Stephen R Souza,
Stuart W Russell,
Sunny R Muir,
Terri E Gibson,
Theresa Kirkham (NMI),
Thomas C Mclean, CFS,
Timothy C Grome,
Vicky L Cruz,
Virgilio F Pacio, CSO,
Wr Bowman,
Yvette E Guillermo,
Zhihao Qiu (Peter), PhD
Juanj Wu's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more